2022-03-31-accounts

CONTENTS		PAGE
Legal and administrative	details
Report ofthe Trustees
Independent Examiner's	Report
Statement offinancial activities
Balance sheet
Notes to the financial statements		S-e

Jeremy	Chataway	- Chairman
Omar Malik
Richard	Nicholas
10L18Laboratory		Block
Charing	Cross Campus
Imperial	College	London
Fulham	Palace Road
Hammersmith
London
W6 8RF

Charity Number	Charity Number	1113598
Accountants	and	Haines Watts
Independent	Examiners	Aissela
		46 High Street
		Esher
		Surrey
		KT10 9QY

		Note		Unrestricted	Restricted	Year to	Year to
				Funds	Funds	2022	2021
				6	6	K	6
Income and endowments	from:
Donations and legacies Charitable activities				57,770		57,770	3,263
Total income				57,770		57,770	3,263
Expenditure on:
Grants and Donafons Paid Charitable activities				23,966 2,173		23,966 2,173	41,162 (420)
Total expenditure				26 139		26,139	40,742
Net (expenditure)/income	and net	movement	in funds	31,631		31,631	~37479,
Reconciliation offunds:
Total funds brought forward				171,615	10,200	181,815	219,294
Total funds carried forward				203,246	10,200	213,446	181,815

Creditors
					Yearto	Year to
					2022f	2021f
Accrued grants payable
Accrued support costs					1,200	1,200
					1,200	1,200
Unrestricted	funds
Year ended	31 March 2022	Balance at 01/04/2021f	Incomef	Expendituref	Transfersf	Balance at 31/03/2022f
General funds		171,615	57,770	(26,139)		203,246
		171,615	57,770	(26,139)		203,246
Year ended	31 March 2021	Balance at 01/04/2020f	Incomef	Expenditure	Transfersf	Balance at 31/03/2021f
General funds		209,094 209,094	3,263 3.263	(40,742) ~40742,		171,615 171,615

Restricted funds	Restricted funds
Year ended 31March 2022		Balance at 01/04/2021 2	Income f			Expenditure	Transfers 8	Balance at 31/03/2022
Genzyme	Therapsut	10,200						10,200
		10,200						10,200
Year ended 31March 2021		Balance at 01/04/2020 8	Income 8			Expenditure 2	Transfers	Balance at 31/03/2021 K
Genzyms	Therapeut	10,200						10,200
		10,200						10,200
Name of	fund	Descri ion nature and		u	uses	ofthe fund
Genzyme	Therapeut	Funds held for the	purpose	of	making	a grant for the	purchase ofan	infusion pump.

enzyme Therapeut Funds held f Analysis ofnet assets between funds	enzyme Therapeut Funds held f Analysis ofnet assets between funds	or the purpose ofmaking a grant for the	purchase ofan infus	ion pump.
Year ended 31March 2022		Unrestricted Funds	Restricted Funds 8	Totalf
Current Current	assets liabilities	204,446 (1,200)	10,200	214,646 (1,200)
		203,246	10,200	213,446
Year ended 31 March 2021		Unrestricted Funds 8	Restricted Fundsf	Total
Current Current	assets liabilities	172,815 (1,200)	10,200	183,015 (1,200)
		171,615	10,200	181,815